Yong Lin

1.7k total citations
46 papers, 1.2k citations indexed

About

Yong Lin is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yong Lin has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Yong Lin's work include Liver Disease Diagnosis and Treatment (17 papers), Liver physiology and pathology (12 papers) and MicroRNA in disease regulation (9 papers). Yong Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver physiology and pathology (12 papers) and MicroRNA in disease regulation (9 papers). Yong Lin collaborates with scholars based in China, United States and Japan. Yong Lin's co-authors include Wei‐Fen Xie, Xin Zeng, Yue-Xiang Chen, Jian Qing Shi, Jian Shi, Xin Zhang, Wei Zhong, Kaiming Wu, Beifang Ning and Junping Zhang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Yong Lin

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Lin China 20 429 416 411 303 254 46 1.2k
Ioanna Delladetsima Greece 17 339 0.8× 378 0.9× 275 0.7× 207 0.7× 98 0.4× 59 1.1k
Jens‐Gerd Scharf Germany 21 359 0.8× 378 0.9× 475 1.2× 203 0.7× 294 1.2× 48 1.4k
Stuart Robinson United Kingdom 20 384 0.9× 493 1.2× 296 0.7× 417 1.4× 103 0.4× 62 1.4k
Koo Jeong Kang South Korea 23 553 1.3× 414 1.0× 374 0.9× 698 2.3× 321 1.3× 82 1.6k
Changqing Yang China 19 697 1.6× 588 1.4× 727 1.8× 456 1.5× 197 0.8× 61 1.9k
Yun Bin Lee South Korea 25 956 2.2× 922 2.2× 406 1.0× 280 0.9× 170 0.7× 105 1.8k
Kazuo Hatsuse Japan 19 324 0.8× 337 0.8× 403 1.0× 358 1.2× 182 0.7× 53 1.5k
Yotaro Kudo Japan 21 226 0.5× 276 0.7× 966 2.4× 265 0.9× 323 1.3× 37 1.9k
Annie L’Helgoualc’h France 22 235 0.5× 218 0.5× 402 1.0× 342 1.1× 168 0.7× 27 1.4k
Sabino Russi Italy 19 497 1.2× 288 0.7× 254 0.6× 299 1.0× 125 0.5× 45 1.3k

Countries citing papers authored by Yong Lin

Since Specialization
Citations

This map shows the geographic impact of Yong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Lin more than expected).

Fields of papers citing papers by Yong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Lin. The network helps show where Yong Lin may publish in the future.

Co-authorship network of co-authors of Yong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Lin. A scholar is included among the top collaborators of Yong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Lin. Yong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yuanyuan, Yarong Hao, Chunyan Sun, et al.. (2025). Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis. Cellular and Molecular Immunology. 22(11). 1414–1426. 1 indexed citations
2.
Lu, Yiting, Yarong Hao, Yuanyuan Luo, et al.. (2024). Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis. Journal of Gastroenterology. 60(3). 340–355.
3.
Zeng, Xin, Jiajun Yu, Lifen Wang, et al.. (2023). Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China. Hepatology International. 18(2). 673–687. 7 indexed citations
4.
Lin, Yong, Zhi Chen, Shiping Chen, et al.. (2022). Temporal and spatial variations of ecosystem photosynthetic parameters in arid and semi-arid areas of China and its influencing factors. Chinese Journal of Plant Ecology. 46(12). 1461–1472. 5 indexed citations
5.
Luo, Yuanyuan, Yiting Lu, Binbin Li, et al.. (2022). Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA. Frontiers in Pharmacology. 13. 819735–819735. 12 indexed citations
6.
Luo, Yuanyuan, Yiting Lu, Binbin Li, et al.. (2021). Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis. Hepatology International. 16(2). 447–462. 6 indexed citations
7.
Cai, Yanping, et al.. (2020). The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID‐19 in Wuhan, China: A retrospective study. Journal of Medical Virology. 92(10). 2124–2129. 15 indexed citations
8.
9.
Wu, Kaiming, Lin Lin, Yimin Chu, et al.. (2016). Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clinical Science. 130(16). 1469–1480. 37 indexed citations
10.
Zhu, Changpeng, Meng Ji, Zhiqian Hu, et al.. (2015). Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy. Current Cancer Drug Targets. 15(1). 27–34. 3 indexed citations
11.
Tang, Nan, Kaiming Wu, Jian Shi, et al.. (2014). MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis. PLoS ONE. 9(10). e108005–e108005. 94 indexed citations
12.
Chen, Jian, Jian Shi, Wei‐Fen Xie, Xin Zeng, & Yong Lin. (2012). Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients. International Journal of Infectious Diseases. 16(10). e748–e752. 3 indexed citations
13.
Teng, Jingfei, Xin Zeng, Jian Shi, Wei Xie, & Yong Lin. (2011). A huge retroperitoneal liposarcoma presenting as a hepatic space‐occupying lesion: A case report. Journal of Digestive Diseases. 13(2). 120–122. 2 indexed citations
14.
Zhu, Changpeng, Jian Shi, Yue-Xiang Chen, Wei‐Fen Xie, & Yong Lin. (2011). Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis. Radiotherapy and Oncology. 99(2). 108–113. 68 indexed citations
15.
Zeng, Xin, Yong Lin, Sheng Xia, et al.. (2010). Combination of taurine with silybin meglumine in treatment of patients with non-alcohlic steatohepatitis. Zhonghua xiaohua zazhi. 30(7). 441–443. 1 indexed citations
16.
Shi, Jian Qing, Zhi Li, Xin Zeng, Yong Lin, & Wei‐Fen Xie. (2009). Ursodeoxycholic acid in primary sclerosing cholangitis: meta‐analysis of randomized controlled trials. Hepatology Research. 39(9). 865–873. 50 indexed citations
17.
Deng, Xing, Xin Zhang, Chuan Yin, et al.. (2008). Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte‐like cells. Journal of Cellular Physiology. 217(1). 138–144. 30 indexed citations
18.
Chen, Siwen, Yue-Xiang Chen, Jian Shi, Yong Lin, & Wei‐Fen Xie. (2006). The Restorative Effect of Taurine on Experimental Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences. 51(12). 2225–2234. 39 indexed citations
19.
Lin, Yong, Wei‐Fen Xie, Xin Zhang, et al.. (2005). Treatment of experimental hepatic fibrosis by combinational delivery of urokinase‐type plasminogen activator and hepatocyte growth factor genes. Liver International. 25(4). 796–807. 37 indexed citations
20.
Wei, Wenxiang, Dorjbal Dorjsuren, Yong Lin, et al.. (2001). Direct Interaction between the Subunit RAP30 of Transcription Factor IIF (TFIIF) and RNA Polymerase Subunit 5, Which Contributes to the Association between TFIIF and RNA Polymerase II. Journal of Biological Chemistry. 276(15). 12266–12273. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioanna Delladetsima Breakdown of academic impact, for papers by Jens‐Gerd Scharf Breakdown of academic impact, for papers by Stuart Robinson Breakdown of academic impact, for papers by Koo Jeong Kang Breakdown of academic impact, for papers by Changqing Yang Breakdown of academic impact, for papers by Yun Bin Lee Breakdown of academic impact, for papers by Kazuo Hatsuse Breakdown of academic impact, for papers by Yotaro Kudo Breakdown of academic impact, for papers by Annie L’Helgoualc’h Breakdown of academic impact, for papers by Sabino Russi
Rankless by CCL
2026